BioSyent (RX) News Today C$12.06 -0.04 (-0.29%) As of 08/29/2025 03:55 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartDividendHeadlinesInsider TradesBuy This Stock RX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Bloom Burton Has Optimistic View of BioSyent FY2026 EarningsAugust 30 at 6:54 AM | marketbeat.comFY2025 Earnings Estimate for BioSyent Issued By Bloom BurtonAugust 29 at 6:09 AM | marketbeat.comFY2025 Earnings Forecast for BioSyent Issued By Bloom BurtonAugust 28 at 2:23 AM | americanbankingnews.comBioSyent Inc. Announces Quarterly Dividend of $0.05 (CVE:RX)August 24, 2025 | marketbeat.comBioSyent (CVE:RX) Reaches New 1-Year High After Dividend AnnouncementAugust 24, 2025 | americanbankingnews.comBioSyent Declares Consistent Q3 2025 DividendAugust 22, 2025 | msn.comBioSyent Inc. Reports Robust Growth in Q2 and H1 2025 Financial ResultsAugust 22, 2025 | msn.comBioSyent Declares Third Quarter 2025 DividendAugust 21, 2025 | financialpost.comFBioSyent Releases Financial Results for Q2 and H1 2025August 21, 2025 | financialpost.comFBioSyent (CVE:RX) Shares Cross Below 50-Day Moving Average - Should You Sell?August 17, 2025 | marketbeat.comBioSyent to Announce Q2 and H1 2025 Financial ResultsAugust 14, 2025 | msn.comBioSyent (CVE:RX) Share Price Passes Below Fifty Day Moving Average - Time to Sell?July 26, 2025 | marketbeat.comBioSyent (CVE:RX) Stock Crosses Below 50-Day Moving Average - Time to Sell?July 17, 2025 | marketbeat.comBiosyent Inc. Stock Price HistoryJune 19, 2025 | investing.comBloom Burton Forecasts BioSyent's FY2025 Earnings (CVE:RX)May 24, 2025 | marketbeat.comBloom Burton Forecasts BioSyent's FY2026 Earnings (CVE:RX)May 23, 2025 | marketbeat.comBioSyent (CVE:RX) Has Announced A Dividend Of CA$0.05May 19, 2025 | finance.yahoo.comBioSyent (CVE:RX) Share Price Crosses Above 50 Day Moving Average - Time to Sell?May 18, 2025 | marketbeat.comHere's Why We Think BioSyent (CVE:RX) Is Well Worth WatchingMay 15, 2025 | finance.yahoo.comBioSyent (CVE:RX) Shares Cross Below 50-Day Moving Average - Here's What HappenedApril 24, 2025 | marketbeat.comCould The Market Be Wrong About BioSyent Inc. (CVE:RX) Given Its Attractive Financial Prospects?April 18, 2025 | finance.yahoo.comBioSyent (CVE:RX) Shares Pass Above 50 Day Moving Average - Here's What HappenedApril 5, 2025 | marketbeat.comFeraMAX® Named #1 Recommended Iron Supplement in Canada by Pharmacists and Physicians for Tenth Consecutive YearApril 1, 2025 | markets.businessinsider.comBioSyent (CVE:RX) Share Price Crosses Above Fifty Day Moving Average - Here's WhyMarch 28, 2025 | marketbeat.comFY2026 Earnings Forecast for BioSyent Issued By Bloom BurtonMarch 20, 2025 | marketbeat.comFY2025 EPS Estimates for BioSyent Increased by Bloom BurtonMarch 19, 2025 | marketbeat.comBioSyent (CVE:RX) Share Price Crosses Below Fifty Day Moving Average - What's Next?March 11, 2025 | marketbeat.comBioSyent (CVE:RX) Stock Passes Above Fifty Day Moving Average - Here's WhyMarch 2, 2025 | marketbeat.comBioSyent (CVE:RX) Stock Crosses Below 50 Day Moving Average - Time to Sell?February 22, 2025 | marketbeat.comBioSyent (CVE:RX) Share Price Passes Below Fifty Day Moving Average - Should You Sell?February 13, 2025 | marketbeat.comBioSyent (CVE:RX) Shares Pass Below 50 Day Moving Average - Time to Sell?February 5, 2025 | marketbeat.comBioSyent (CVE:RX) Stock Passes Above Two Hundred Day Moving Average - Should You Sell?January 28, 2025 | marketbeat.comBioSyent (CVE:RX) Stock Passes Above 50 Day Moving Average - Time to Sell?January 10, 2025 | marketbeat.comBioSyent (CVE:RX) Stock Price Passes Above Fifty Day Moving Average - What's Next?January 10, 2025 | marketbeat.comBioSyent (CVE:RX) Share Price Passes Above 50-Day Moving Average - What's Next?January 2, 2025 | marketbeat.comFAX Capital Corp. Sells 112,400 Shares of BioSyent Inc. (CVE:RX) StockDecember 24, 2024 | insidertrades.comBioSyent Inc. (CVE:RX) Insider FAX Capital Corp. Sells 112,400 SharesDecember 23, 2024 | marketbeat.comInvesting in BioSyent (CVE:RX) five years ago would have delivered you a 110% gainDecember 15, 2024 | uk.finance.yahoo.comBioSyent (CVE:RX) Sets New 52-Week High - Time to Buy?December 13, 2024 | marketbeat.comBioSyent Inc. (CVE:RX) Senior Officer Sells C$55,628.75 in StockDecember 13, 2024 | insidertrades.comInsider Selling: BioSyent Inc. (CVE:RX) Insider Sells 65,000 Shares of StockNovember 27, 2024 | insidertrades.comBioSyent Inc. (CVE:RX) Insider FAX Capital Corp. Sells 230,800 SharesNovember 26, 2024 | insidertrades.comFY2024 Earnings Estimate for BioSyent Issued By Bloom BurtonNovember 25, 2024 | marketbeat.comBioSyent Inc. (RX.V)November 24, 2024 | finance.yahoo.comBioSyent Inc. (CVE:RX) Will Pay A CA$0.045 Dividend In Four DaysNovember 24, 2024 | finance.yahoo.comCalculating The Fair Value Of BioSyent Inc. (CVE:RX)November 22, 2024 | finance.yahoo.comBioSyent Inc. (BIOYF)November 21, 2024 | finance.yahoo.comBioSyent Inc.November 13, 2024 | wsj.comBioSyent (CVE:RX) Stock Passes Below Fifty Day Moving Average - What's Next?November 13, 2024 | marketbeat.comBioSyent (CVE:RX) Sets New 1-Year High - Should You Buy?November 4, 2024 | marketbeat.com Get BioSyent News Delivered to You Automatically Sign up to receive the latest news and ratings for RX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RX Media Mentions By Week RX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RX News Sentiment▼0.571.05▲Average Medical News Sentiment RX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RX Articles This Week▼81▲RX Articles Average Week Get the Latest News and Ratings for RX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for BioSyent and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Aurora Cannabis News Canopy Growth News Cipher Pharmaceuticals News Organigram News Cardiol Therapeutics News HLS Therapeutics News SugarBud Craft Growers News Medexus Pharmaceuticals News MediPharm Labs News Willow Biosciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:RX) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMy NEXT $1 Trillion PredictionJames Altucher is making his next trillion-dollar prediction — and this time, it’s not Apple. He believes Elon...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioSyent Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioSyent With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RX Stock Alerts